Food for thought... on animal tests;Vor- und nachdenkliches... zu tierversuchen

Altex

Volumn 25, Issue 1, 2008, Pages 3-16

  Hartung, Thomas ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AMBIGUITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TESTING ALTERNATIVE; CLINICAL PROTOCOL; CONFLICT; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMIC ASPECT; FACE VALIDITY; JUVENILE ANIMAL; LETHALITY; NONHUMAN; PHILOSOPHY; POST HOC ANALYSIS; REVIEW; SAMPLE SIZE; SEX DIFFERENCE; SPECIES DIFFERENCE; TOXICITY TESTING; AGING; ANIMAL; ARTICLE; METHODOLOGY; STANDARD;

AGING; ANIMAL TESTING ALTERNATIVES; ANIMALS;

EID: 48949104862     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Basketter, D. A., York, M., McFadden, J. P. and Robinson, M. K. (2004). Determination of skin irritation potential in the human 4-h patch test. Contact Dermatitis 51, 1-4. (Pubitemid 39127945)
2. Bhogal, N. and Combes, R. (2006). TGN1412: time to change the paradigm for the testing of new pharmaceuticals. ATLA 34, 225-239. (Pubitemid 43844405)
3. Bitsch, A., Jacobia, S., Melbera, C. et al. (2006). REPDOSE: A database on repeated dose toxicity studies of commercial chemicals - a multifunctional tool. Reg. Tox. Pharmacol. 46, 202-210. (Pubitemid 44692902)
4. Bokkers, B. G. and Slob, W. (2007). Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach. Crit. Rev. Toxicol. 37, 355-373. (Pubitemid 47035214)
5. Bottini, A. M., Amcoff, P. and Hartung, T. (2007). Food for thought ... on globalization of alternative methods. ALTEX 24, 255-261.
6. Brodie, B. (1964). Of mice, microsomes and man. Pharmacologist 6, 12-26.
7. Chapman, K. and Robinson, S. (2007). Challenging the regulatory requirement for acute toxicity studies in the development of new medicines - a workshop report. http://www.nc3rs.org.uk/downloaddoc.asp?id=559&page= 22&skin=0
8. Committee on Toxicity and Assessment of Environmental Agents, National Research Council. (2007). Toxicity Testing in the Twenty-first Century: A Vision and a Strategy, http://www.nap.edu/catalog/11970.html
9. Dawkins, R. (2006). The god delusion. London: Bantam Press.
10. Deitch, E. A., Rutan, R. and Waymack, J. P. (1996). Trauma, shock, and gut translocation. New Horiz. 4, 289-299 (Pubitemid 26171435)
11. Falk-Filipsson, A., Hanberg, A., Victorin, K. et al. (2007). Assessment factors - applications in health risk assessment of chemicals. Environ. Res. 104, 108-127.
12. Festing, M. F. (1993). Genetic variation in outbred rats and mice and its implications for toxicological screening. J. Exp. Anim. Sci. 35, 210-220.
13. Fleischer, M. (2007). Testing cost and testing capacity according to REACH requirements - results of a survey of independent and corporate GLP laboratories in the EU and Switzerland. J. Business Chem. 4, 96-114.
14. Gandhi, M., Aweeka, F., Greenblatt, R. M. and Blaschke, T. F. (2004). Sex differences in pharmacokinetics and pharmacodynamics. Annu. Rev. Pharmacol. Toxicol. 44, 499-523. (Pubitemid 38263851)
15. Gatt, M., Reddy, B. S. and MacFie, J. (2007). Review article: bacterial translocation in the critically ill - evidence and methods of prevention. Aliment. Pharmacol. Ther. 25, 741-757. (Pubitemid 46437210)
16. Grass, G. M. and Sinko, P. J. (2002). Physiology-based pharmacokinetic simulation modelling. Adv. Drug Delivery Rev. 43, 433-451.
17. Hartung, T. (2007a). Food for thought ... on validation. ALTEX 24(2), 67-72.
18. Hartung, T. (2007b). Food for thought ... on cell culture. ALTEX 24(3), 143-147.
19. Hoffmann, S. and Hartung, T. (2005). Diagnosis: Toxic! - Trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. Tox. Sci. 85, 422-428. (Pubitemid 40614273)
20. Hoffmann, S. and Hartung, T. (2006). Towards an evidence-based toxicology. Human Exp. Toxicol. 25, 497-513.
21. IGHRC (The Interdepartmental Group of Health Risks from Chemicals UK). (2003). Uncertainty factor: their use in human health risk assessment by UK government. MRC Institute for Environment and Health, 1-68, http://www.le.ac.uk/ ieh/
22. Inaba, T., Nebert, D. W., Burchell, B. et al. (1995). Pharmacogenetics in clinical pharmacology and toxicology. Can. J. Physiol. Pharmacol. 73, 331-338.
23. Kacew, S. and Festing, M. F. (1996). Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. J. Toxicol. Environ. Health 47, 1-30. (Pubitemid 26049506)
24. Kamrin, M. A. (2007). The "low dose" hypothesis: validity and implications for human risk. Int. J. Toxicol. 26, 13-23.
25. Lee, A. (2000). Animal models of gastroduodenal ulcer disease. Baillieres Best Pract. Res. Clin. Gastroenterol. 14, 75-96. (Pubitemid 30153884)
26. Lin, J. H. (2007). Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy. Curr. Drug Metab. 8(2), 109-136 (Pubitemid 46218679)
27. Lipscomb, J. C. and Kedderis, G. L. (2002). Incorporating human interindividual biotransformation variance in health risk assessment. Sci. Total Environ. 288, 13-21. (Pubitemid 34233689)
28. Lovell, D. P. (1993). Impact of pharmacogenetics on toxicological studies. Statistical implications. J. Exp. Anim. Sci. 35, 259-281. (Pubitemid 23301087)
29. Mehendale, H. M. (1995). Toxicodynamics of low level toxicant interactions of biological significance: inhibition of tissue repair. Toxicology 105, 251-266. (Pubitemid 26038247)
30. Stechmiller, J. K., Treloar, D. and Allen, N. (1997). Gut dysfunction in critically ill patients: a review of the literature. Am. J. Crit. Care 6, 204-209. (Pubitemid 127457725)
31. Sumner, D. D. and Stevens, J. T. (1994). Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion. Environ. Health Perspect. 102 Suppl 11, 13-22.
32. Szyf, M. (2007). The dynamic epigenome and its implications in toxicology. Toxicol. Sci. 100, 7-23. (Pubitemid 47617798)
33. Wolfer, D. P., Litvin, O., Morf, S. et al. (2004). Laboratory animal welfare: Cage enrichment and mouse behaviour. Nature 432, 821-822.
34. Wood, A. J. (1998). Ethnic differences in drug disposition and response. Ther. Drug Monit. 20, 525-526. (Pubitemid 28463443)
35. York, M., Griffiths, H. A., Whittle, E. and Basketter, D. A. (1996). Evaluation of a human patch test for the identification and classification of skin irritation potential. Contact Dermatitis 34, 204-212. (Pubitemid 26083674)